Quantcast

Latest Oncologists Stories

2014-04-23 08:32:21

Fort Lauderdale-based event to provide stomach cancer patients and their families unparalleled access to hear from eight world-renowned experts in the field of stomach cancer FT. LAUDERDALE, Fla., April 23, 2014 /PRNewswire/ -- Debbie's Dream Foundation: Curing Stomach Cancer (DDF), a non-profit organization that raises awareness and funds for stomach cancer, is proud to host its fourth annual "Stomach Cancer Education Symposium & Webinar." The live event and webinar will be held...

2014-04-23 08:31:00

Third Phase 3 Trial of Custirsen to Receive FDA Fast Track Designation BOTHELL, Wash. and VANCOUVER, British Columbia, April 23, 2014 /PRNewswire/ -- OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to the investigation of custirsen when administered in combination with cabazitaxel/prednisone for the treatment of men with metastatic castrate-resistant prostate cancer (CRPC) following...

2014-04-08 00:21:50

Fox Family Cancer Research Funding Trust Is Contributing to Support Team SAN DIEGO, April 7, 2014 /PRNewswire-USNewswire/ -- Stand Up To Cancer (SU2C), The Lustgarten Foundation, and the Fox Family Cancer Research Funding Trust, along with the American Association for Cancer Research (AACR), SU2C's Scientific Partner, announced the formation of a Dream Team dedicated to pancreatic cancer research during a press event today at the AACR Annual Meeting 2014, held here April 5-9. Elizabeth M....

2014-04-03 08:30:01

Joins Renowned Academic Scientists Charles Sawyers, Jose Baselga and Ronald Evans SAN DIEGO, April 3, 2014 /PRNewswire/ -- Seragon Pharmaceuticals Inc., a clinical-stage biotechnology company focused on the development of drugs for hormone-driven cancers, today announced the expansion of the company's Clinical and Scientific Advisory Board (CSAB) and the appointment of Debasish Roychowdhury, M.D., who will serve as Seragon's Acting Chief Medical Officer....

2014-04-02 12:31:14

SANTA MONICA, Calif., April 2, 2014 /PRNewswire/ -- Kite Pharma, Inc. (Kite), a clinical-stage biopharmaceutical company focused on developing engineered autologous T cell therapy (eACT(TM)) products for cancer, today announced the appointment of Arie Belldegrun, M.D., FACS, as President and Chief Executive Officer. Dr. Belldegrun, who is also a founder of Kite, will continue in his current role as Chairman of the Company. "Dr. Belldegrun has had a distinguished 18-year tenure in...

2014-04-02 04:21:20

WHIPPANY, N.J., April 2, 2014 /PRNewswire/ -- Bayer HealthCare Pharmaceuticals Inc. today announced that the company has begun to enroll patients in a trial studying Xofigo(®) (radium Ra 223 dichloride) injection in combination with abiraterone acetate and prednisone/prednisolone for the treatment of asymptomatic or mildly symptomatic chemotherapy-naive patients with bone predominant metastatic castration-resistant prostate cancer (mCRPC). The randomized, double-blind, placebo-controlled...

2014-03-24 23:00:59

Understanding bone health is critical for advanced stage prostate cancer patients. Malecare Cancer Support is presenting a free teleconference for prostate cancer patients and their families with noted urologist Neil Shore, MD. New York, NY (PRWEB) March 24, 2014 Malecare Prostate Cancer Support will present a teleconference titled, "Bone Health and Prostate Cancer.” The conference is scheduled for Tuesday, March 25, 2014 at 6PM ET. The teleconference is available without cost and...

2014-03-13 12:28:48

LINTHICUM, Md., March 13, 2014 /PRNewswire-USNewswire/ -- The American Urological Association (AUA) and Astellas US LLC, a U.S. affiliate of Tokyo-based Astellas Pharma Inc., have announced a $3 million commitment to the Urology Care Foundation and to the promising young urologists seeking careers in academic urology. The gift, the largest ever awarded to the Urology Care Foundation, will maintain its research program supporting surgeon-scientists, the Rising Star in Urology Research...

2014-03-10 16:32:17

RICKMANSWORTH, England, March 10, 2014 /PRNewswire/ -- Lightpoint Medical announced today that the company and its surgical collaborators have received GBP1.7M ($2.8M) in grant funding from the UK's innovation agency, the Technology Strategy Board. The grant funding will be used for clinical trials of Lightpoint's intra-operative imaging technology in breast cancer and prostate cancer surgery. Collaborators on the clinical trials include Guy's and St Thomas' NHS Foundation...

2014-03-07 08:25:07

In the news release, Dr. Spiller skin care named "Caring Partner" of Oncology Esthetics® USA, a division of Touch For Cancer, issued 06-Mar-2014 by Spiller U.S. over PR Newswire, we are advised by the company that the originally included photo should be omitted entirely. The complete, corrected release sans photo follows: Dr. Spiller skin care named "Caring Partner" of Oncology Esthetics® USA, a division of Touch For Cancer ATLANTA, March 6, 2014 /PRNewswire/ -- Oncology...


Word of the Day
malpais
  • The ragged surface of a lava-flow.
'Malpais' translates from Spanish as 'bad land.'